Emodin attenuates adenosine triphosphate ‑induced pancreatic ductal cell injury in vitro via the inhibition of the P2X7/NLRP3 signaling pathway.
This study suggests that emodin may be further developed for its application in future medical therapy.
PMID: 31524270 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research